ÂÜÀòÂÒÂ×

Gurleen Saini is a highly experienced professional in the field of immunogenicity characterization, currently serving as a Sr. Principal Scientist at Boehringer Ingelheim since August 2022. Prior to this role, Gurleen held positions at Amgen as a Principal Scientist and Scientist, specializing in the development and validation of bioanalytical methods for antibody detection. Experience at Covance included serving as a Lead Scientist, where responsibilities encompassed oversight of GLP, GCP studies, and client interactions, alongside contributions to scientific investigations and mentoring. Gurleen's career began at PPD as an Associate Scientist, where skills in ligand binding and cell-based assays were developed. Educational qualifications include a Master of Science in Biotechnology-Regulatory Affairs from The Johns Hopkins University and a Bachelor's degree in Biology from the University of North Carolina Wilmington.